Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LIVN LivaNova	$53.14 +0.1%	$45.36	$32.48 ▼ $57.35	$2.91B	0.92	709,099 shs	327,004 shs
PRCT PROCEPT BioRobotics	$39.70 -1.7%	$55.73	$37.12 ▼ $103.81	$2.21B	1.05	1.02 million shs	715,868 shs
WEDXF Westaim	$21.64 -0.6%	$22.32	$16.62 ▼ $25.98	$726.21M	0.23	6,371 shs	170 shs
WRBY Warby Parker	$26.51 -1.1%	$22.87	$12.69 ▼ $29.73	$2.79B	2.09	2.25 million shs	1.39 million shs

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LIVN LivaNova	+4.78%	+12.04%	+20.67%	+21.09%	+19.96%
PRCT PROCEPT BioRobotics	+4.61%	-11.62%	-30.58%	-30.51%	-37.49%
WEDXF Westaim	0.00%	+1.78%	-2.51%	-5.51%	+638.31%
WRBY Warby Parker	+10.01%	+10.43%	+16.57%	+52.62%	+106.54%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
LIVN LivaNova	2.0786 of 5 stars	2.5	3.0	2.0	1.7	1.3
PRCT PROCEPT BioRobotics	3.073 of 5 stars	4.4	1.0	2.2	2.5	0.6
WEDXF Westaim	1.1523 of 5 stars	0.0	5.0	2.9	0.0	0.6
WRBY Warby Parker	2.0282 of 5 stars	2.3	2.0	3.1	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
LIVN LivaNova	3.00	Buy	$59.29	11.57% Upside
PRCT PROCEPT BioRobotics	2.78	Moderate Buy	$74.88	88.59% Upside
WEDXF Westaim	0.00	N/A	N/A	N/A
WRBY Warby Parker	2.58	Moderate Buy	$24.06	-9.22% Downside

Current Analyst Ratings Breakdown

Latest WEDXF, PRCT, WRBY, and LIVN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/8/2025	WRBY Warby Parker	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
8/8/2025	WRBY Warby Parker	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$20.00 ➝ $23.00
8/8/2025	WRBY Warby Parker	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$21.00 ➝ $22.00
8/7/2025	WRBY Warby Parker	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Positive ➝ Positive
8/7/2025	PRCT PROCEPT BioRobotics	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$75.00 ➝ $58.00
8/7/2025	PRCT PROCEPT BioRobotics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$80.00 ➝ $55.00
8/7/2025	WRBY Warby Parker	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$28.00
8/7/2025	WRBY Warby Parker	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$24.00 ➝ $28.00
8/5/2025	WRBY Warby Parker	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Neutral ➝ Neutral	$24.00
8/1/2025	WRBY Warby Parker	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$22.00 ➝ $28.00
7/30/2025	WRBY Warby Parker	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Outperform ➝ Outperform	$24.00 ➝ $30.00

(Data available from 8/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
LIVN LivaNova	$1.25B	2.31	$4.45 per share	11.94	$20.56 per share	2.58
PRCT PROCEPT BioRobotics	$274.95M	8.03	N/A	N/A	$6.93 per share	5.73
WEDXF Westaim	$17.04M	42.62	N/A	N/A	$23.28 per share	0.93
WRBY Warby Parker	$821.35M	3.39	$0.37 per share	71.90	$3.44 per share	7.70

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
LIVN LivaNova	$63.23M	-$3.89	N/A	16.92	N/A	-16.13%	14.57%	6.91%	10/29/2025 (Estimated)
PRCT PROCEPT BioRobotics	-$91.41M	-$1.55	N/A	N/A	N/A	-30.60%	-23.73%	-17.34%	10/27/2025 (Estimated)
WEDXF Westaim	-$16.18M	-$2.17	N/A	∞	N/A	-253.76%	-9.36%	-8.82%	8/14/2025 (Estimated)
WRBY Warby Parker	-$20.39M	-$0.07	N/A	265.05	N/A	-1.12%	-0.79%	-0.41%	N/A

Latest WEDXF, PRCT, WRBY, and LIVN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2025	Q2 2025	LIVN LivaNova	$0.84	$1.05	+$0.21	$0.50	$332.20 million	$352.50 million
8/6/2025	Q2 2025	PRCT PROCEPT BioRobotics	-$0.41	-$0.35	+$0.06	-$0.35	$75.67 million	$79.18 million
5/14/2025	Q1 2025	WEDXF Westaim	-$0.0316	-$0.34	-$0.3084	-$0.34	$1.34 million	($4.70) million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
LIVN LivaNova	N/A	N/A	N/A	N/A	N/A
PRCT PROCEPT BioRobotics	N/A	N/A	N/A	N/A	N/A
WEDXF Westaim	N/A	N/A	N/A	N/A	N/A
WRBY Warby Parker	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
LIVN LivaNova	0.31	1.29	1.09
PRCT PROCEPT BioRobotics	0.13	9.21	7.86
WEDXF Westaim	N/A	11.40	11.40
WRBY Warby Parker	N/A	2.55	2.30

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
LIVN LivaNova	97.64%
PRCT PROCEPT BioRobotics	89.46%
WEDXF Westaim	N/A
WRBY Warby Parker	93.24%

Insider Ownership

Company	Insider Ownership
LIVN LivaNova	0.29%
PRCT PROCEPT BioRobotics	6.60%
WEDXF Westaim	4.21%
WRBY Warby Parker	18.24%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
LIVN LivaNova	2,900	54.60 million	54.44 million	Optionable
PRCT PROCEPT BioRobotics	430	55.64 million	51.96 million	Optionable
WEDXF Westaim	7	33.56 million	32.14 million	Not Optionable
WRBY Warby Parker	3,780	105.19 million	86.00 million	Optionable

WEDXF, PRCT, WRBY, and LIVN Headlines

Recent News About These Companies

Stocks Showing Market Leadership: Warby Parker Earns 93 RS Rating

1 hour ago | msn.com

Warby Parker CFO Steve Miller Resigns

August 14 at 9:59 AM | theglobeandmail.com

Telsey Advisory Sticks to Its Buy Rating for Warby Parker (WRBY)

August 14 at 9:59 AM | theglobeandmail.com

The 5 Most Interesting Analyst Questions From Warby Parker’s Q2 Earnings Call

August 14 at 9:59 AM | finance.yahoo.com

Teresa Briggs Sells 6,000 Shares of Warby Parker Inc. (NYSE:WRBY) Stock

August 14 at 7:56 AM | insidertrades.com

Connor Clark & Lunn Investment Management Ltd. Has $5.09 Million Position in Warby Parker Inc. (NYSE:WRBY)

August 14 at 4:33 AM | marketbeat.com

Warby Parker Inc. (NYSE:WRBY) Position Trimmed by AIA Group Ltd

August 13 at 5:43 AM | marketbeat.com

236,623 Shares in Warby Parker Inc. (NYSE:WRBY) Acquired by King Luther Capital Management Corp

August 13 at 4:59 AM | marketbeat.com

Warby Parker’s Earnings Call: Growth and Strategic Moves

August 13 at 4:35 AM | msn.com

WRBY Q2 Deep Dive: Retail Expansion, AI Partnerships, and Margin Leverage Define the Quarter

August 12 at 6:33 PM | msn.com

Warby Parker Inc. (NYSE:WRBY) Shares Sold by Polen Capital Management LLC

August 11 at 8:18 AM | marketbeat.com

Warby Parker Gets Price Target Hikes On Strong Q2 Report, Google AI Glasses Optimism

August 11 at 7:47 AM | msn.com

How Warby Parker Has Kept the Price of Glasses at $95 for 15 Years

August 10, 2025 | wsj.com

21,662 Shares in Warby Parker Inc. (NYSE:WRBY) Acquired by XTX Topco Ltd

August 10, 2025 | marketbeat.com

Stifel Nicolaus Increases Warby Parker (NYSE:WRBY) Price Target to $22.00

August 9, 2025 | marketbeat.com

Jefferies Financial Group Inc. Makes New $292,000 Investment in Warby Parker Inc. (NYSE:WRBY)

August 9, 2025 | marketbeat.com

Zurcher Kantonalbank Zurich Cantonalbank Sells 64,236 Shares of Warby Parker Inc. (NYSE:WRBY)

August 9, 2025 | marketbeat.com

Loop Capital Markets Reaffirms Their Buy Rating on Warby Parker (WRBY)

August 9, 2025 | theglobeandmail.com

Warby Parker Shares Slip After Giving Up Early Gains Despite Strong Q2 Results and Raised Outlook

August 8, 2025 | benzinga.com

Warby Parker’s (NYSE:WRBY) Q2 Sales Top Estimates

August 8, 2025 | msn.com

Telsey Advisory Group Reiterates "Outperform" Rating for Warby Parker (NYSE:WRBY)

August 8, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

WEDXF, PRCT, WRBY, and LIVN Company Descriptions

LivaNova NASDAQ:LIVN

$53.14 +0.08 (+0.14%)

As of 03:04 PM Eastern

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

PROCEPT BioRobotics NASDAQ:PRCT

$39.70 -0.68 (-1.68%)

As of 03:04 PM Eastern

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Westaim OTCMKTS:WEDXF

$21.64 -0.14 (-0.65%)

As of 10:03 AM Eastern

The Westaim Corporation is a private equity firm specializing in direct and indirect investments through acquisitions, joint ventures, secondary investments both direct and indirect, fund of fund investments, and other arrangements. For direct investments, the firm invests in early venture, mid venture, late venture, middle market, later stage, mature, emerging growth, PIPEs, and buyout transactions. For fund of fund investments, it seeks to invest in private equity funds, venture capital funds, and hedge funds. The firm seeks to provide long term capital to businesses operating in the global financial services industry. It typically acquires controlling interests in businesses. The firm seeks to acquire debt, equity, or derivative securities of both public and private companies. It invests with the objective of providing its shareholders with capital appreciation and real wealth preservation. The firm seeks to provide its portfolio companies with advisory services including, but not limited to, advice on capital allocation, financing strategy, performance measurement and merger and acquisition support. It also seeks to partner with like-minded providers of third party capital to help supplement the firm's own capital, when completing acquisitions. The firm generally seeks to hold its investments for seven to 15 years. The Westaim Corporation was founded in 1996 and is based in Toronto, Canada.

Warby Parker NYSE:WRBY

$26.50 -0.31 (-1.14%)

As of 03:04 PM Eastern

Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time